These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37393692)

  • 21. Quantitative structural characterization of local N-glycan microheterogeneity in therapeutic antibodies by energy-resolved oxonium ion monitoring.
    Toyama A; Nakagawa H; Matsuda K; Sato TA; Nakamura Y; Ueda K
    Anal Chem; 2012 Nov; 84(22):9655-62. PubMed ID: 23004563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.
    Qu M; An B; Shen S; Zhang M; Shen X; Duan X; Balthasar JP; Qu J
    Mass Spectrom Rev; 2017 Nov; 36(6):734-754. PubMed ID: 27097288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Integrated Strategy Reveals Complex Glycosylation of Erythropoietin Using Mass Spectrometry.
    Guan Y; Zhang M; Gaikwad M; Voss H; Fazel R; Ansari S; Shen H; Wang J; Schlüter H
    J Proteome Res; 2021 Jul; 20(7):3654-3663. PubMed ID: 34110173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances in Biologic Therapeutic N-Glycan Preparation Techniques and Analytical Methods for Facilitating Biomanufacturing Automation.
    Tiwold EK; Gyorgypal A; Chundawat SPS
    J Pharm Sci; 2023 Jun; 112(6):1485-1491. PubMed ID: 36682489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discrepancies between High-Resolution Native and Glycopeptide-Centric Mass Spectrometric Approaches: A Case Study into the Glycosylation of Erythropoietin Variants.
    Čaval T; Buettner A; Haberger M; Reusch D; Heck AJR
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):2099-2104. PubMed ID: 33856811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-glycan Analysis in Molecular Medicine: Innovator and Biosimilar Protein Therapeutics.
    Borza B; Hajba L; Guttman A
    Curr Mol Med; 2020; 20(10):828-839. PubMed ID: 33272172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive Physicochemical and Biological Characterization of the Proposed Biosimilar Darbepoetin Alfa, LBDE, and Its Originator Darbepoetin Alfa, NESP
    Jeong YR; Jeong RU; Son JH; Kwon JC; Jung S; Song MA; Hwang JA; Lee GM
    BioDrugs; 2018 Apr; 32(2):153-168. PubMed ID: 29556960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Integrated Mass Spectroscopy Data Processing Strategy for Fast Identification, In-Depth, and Reproducible Quantification of Protein
    Zhao X; Zheng S; Li Y; Huang J; Zhang W; Xie Y; Qin W; Qian X
    Anal Chem; 2020 Jan; 92(1):690-698. PubMed ID: 31859485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiling of a high mannose-type N-glycosylated lipase using hydrophilic interaction chromatography-mass spectrometry.
    Gargano AFG; Schouten O; van Schaick G; Roca LS; van den Berg-Verleg JH; Haselberg R; Akeroyd M; Abello N; Somsen GW
    Anal Chim Acta; 2020 May; 1109():69-77. PubMed ID: 32252907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of intact glycopeptides reveals the impact of culture media on site-specific glycosylation of EPO-Fc fusion protein generated by CHO-GS cells.
    Wang Q; Yang G; Wang T; Yang W; Betenbaugh MJ; Zhang H
    Biotechnol Bioeng; 2019 Sep; 116(9):2303-2315. PubMed ID: 31062865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid Intact mass based multi-attribute method in support of mAb upstream process development.
    Lanter C; Lev M; Cao L; Loladze V
    J Biotechnol; 2020 May; 314-315():63-70. PubMed ID: 32294517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sweet spot for biologics: recent advances in characterization of biotherapeutic glycoproteins.
    O'Flaherty R; Trbojević-Akmačić I; Greville G; Rudd PM; Lauc G
    Expert Rev Proteomics; 2018 Jan; 15(1):13-29. PubMed ID: 29130774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of a residual host cell protein hexosaminidase B associated with N-glycan degradation during the stability study of a therapeutic recombinant monoclonal antibody product.
    Li X; An Y; Liao J; Xiao L; Swanson M; Martinez-Fonts K; Pavon JA; Sherer EC; Jawa V; Wang F; Gao X; Letarte S; Richardson DD
    Biotechnol Prog; 2021 May; 37(3):e3128. PubMed ID: 33476097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intact glycopeptide characterization using mass spectrometry.
    Cao L; Qu Y; Zhang Z; Wang Z; Prytkova I; Wu S
    Expert Rev Proteomics; 2016 May; 13(5):513-22. PubMed ID: 27140194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dilute-and-shoot analysis of therapeutic monoclonal antibody variants in fermentation broth: a method capability study.
    Regl C; Wohlschlager T; Esser-Skala W; Wagner I; Samonig M; Holzmann J; Huber CG
    MAbs; 2019 Apr; 11(3):569-582. PubMed ID: 30668249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Top-Down Mass Spectrometry.
    Roberts DS; Mann M; Melby JA; Larson EJ; Zhu Y; Brasier AR; Jin S; Ge Y
    J Am Chem Soc; 2021 Aug; 143(31):12014-12024. PubMed ID: 34328324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential fragment ion filtering and endoglycosidase-assisted identification of intact glycopeptides.
    Yu Z; Zhao X; Tian F; Zhao Y; Zhang Y; Huang Y; Qian X; Ying W
    Anal Bioanal Chem; 2017 May; 409(12):3077-3087. PubMed ID: 28258464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cation exchange chromatography on a monodisperse 3 µm particle enables extensive analytical similarity assessment of biosimilars.
    Füssl F; Millán-Martín S; Bones J; Carillo S
    J Pharm Biomed Anal; 2023 Sep; 234():115534. PubMed ID: 37343453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycan Remodeling of Human Erythropoietin (EPO) Through Combined Mammalian Cell Engineering and Chemoenzymatic Transglycosylation.
    Yang Q; An Y; Zhu S; Zhang R; Loke CM; Cipollo JF; Wang LX
    ACS Chem Biol; 2017 Jun; 12(6):1665-1673. PubMed ID: 28452462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.